We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,802 hedge funds and large institutions have $249B invested in Johnson & Johnson in 2024 Q2 according to their latest regulatory filings, with 162 funds opening new positions, 1,507 increasing their positions, 1,791 reducing their positions, and 154 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $2.12B | Put options by funds: $1.78B

1.01% more ownership

Funds ownership: 69.87%70.88% (+1%)

5% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 154

1% less funds holding

Funds holding: 3,8493,802 (-47)

6% less capital invested

Capital invested by funds: $266B → $249B (-$16.5B)

16% less repeat investments, than reductions

Existing positions increased: 1,507 | Existing positions reduced: 1,791

19% less funds holding in top 10

Funds holding in top 10: 204165 (-39)

Holders
3,802
Holders Change
-47
Holders Change %
-1.22%
% of All Funds
54.9%
Holding in Top 10
165
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-19.12%
% of All Funds
2.38%
New
162
Increased
1,507
Reduced
1,791
Closed
154
Calls
$2.12B
Puts
$1.78B
Net Calls
+$333M
Net Calls Change
-$99.1M
Name Holding Trade Value Shares
Change
Change in
Stake
LDB
601
Lee, Danner & Bass
Tennessee
$17.8M +$18.1M +121,441 New
NMERB
602
New Mexico Educational Retirement Board
New Mexico
$17.7M
CCB
603
Country Club Bank
Missouri
$17.7M +$3.58M +24,052 +25%
FLII
604
First Long Island Investors
New York
$17.7M -$9.32M -62,670 -34%
CA
605
Callahan Advisors
Texas
$17.6M +$355K +2,388 +2%
CSPIA
606
Cary Street Partners Investment Advisory
Virginia
$17.6M +$308K +2,074 +2%
LRPA
607
L. Roy Papp & Associates
Arizona
$17.4M +$26.9K +181 +0.2%
RT
608
Rockland Trust
Massachusetts
$17.3M +$293K +1,969 +2%
TSW
609
Thompson Siegel & Walmsley
Virginia
$17.2M -$134K -901 -0.8%
MCM
610
Mill Capital Management
North Carolina
$17.2M +$302K +2,029 +2%
BRWA
611
B. Riley Wealth Advisors
Florida
$17.1M -$4.65M -31,236 -21%
Impax Asset Management Group
612
Impax Asset Management Group
United Kingdom
$17.1M -$266K -1,790 -2%
SA
613
SpiderRock Advisors
Delaware
$17.1M -$1.07M -7,221 -6%
BPWM
614
Badgley Phelps Wealth Managers
Washington
$17.1M +$30.6K +206 +0.2%
SWP
615
Stratos Wealth Partners
Ohio
$17M -$451K -3,033 -3%
P
616
&Partners
Tennessee
$16.8M +$12.4M +83,044 +260%
TG
617
TCW Group
California
$16.8M -$3.71M -24,929 -18%
CA
618
Cornerstone Advisors
North Carolina
$16.8M
MLL
619
Moody Lynn & Lieberson
Massachusetts
$16.7M +$805K +5,414 +5%
WDA
620
Wendell David Associates
New Hampshire
$16.7M +$11.2K +75 +0.1%
NW
621
NewEdge Wealth
Pennsylvania
$16.7M -$403K -2,707 -2%
AWAG
622
ARS Wealth Advisors Group
Florida
$16.7M +$995K +6,692 +6%
JMFC
623
J.M. Forbes & Co
Massachusetts
$16.6M +$212K +1,423 +1%
IAA
624
Independent Advisor Alliance
North Carolina
$16.6M -$4.04M -27,184 -19%
VPIM
625
Vanguard Personalized Indexing Management
California
$16.5M -$1.76M -11,803 -7%

JNJ Hedge Fund Activity: Q2 2024 in Review

3,802 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2024, worth a combined $249B — down 6.2% from $266B a quarter earlier.

Buyers outnumbered sellers: 162 funds opened new JNJ positions and 154 closed out — a net gain of 8 holders — while 1,507 added to existing stakes and 1,791 trimmed.

The largest buyer was BlackRock, adding an estimated $1.26B. The largest seller was Capital International Investors, cutting an estimated $1.8B.

  • 3,802 institutional investors held Johnson & Johnson (JNJ) as of Q2 2024, down from 3,849 in Q1 2024.
  • Funds reported $249B of Johnson & Johnson stock for Q2 2024, down 6.2% quarter-over-quarter.
  • 162 funds opened new Johnson & Johnson positions in Q2 2024 and 154 closed out, a net change of +8 holders.
  • The largest Johnson & Johnson buyer in Q2 2024 was BlackRock, an estimated $1.26B added.
  • The largest Johnson & Johnson seller in Q2 2024 was Capital International Investors, an estimated $1.8B sold.

Based on aggregated 13F filings for Q2 2024.